Age: 50.0
Sex: U
Vaccine: COVID19
Symptoms: Immunisation, Intestinal obstruction, Nausea, Vomiting
Clinical narrative: intestinal infection; severe abdominal pains; nausea; diarrhea; vomiting; intestinal infection or blockage; booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50 year-old patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 06Nov2021 09:30 (Lot number: 30145BA) at the age of 50 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "High Blood pressure", start date: Jul2014 (ongoing); "Depression", start date: Aug2018 (ongoing); "diverticulosis/ internal hem", start date: Jan2016 (ongoing); "anxiety", start date: Aug2018 (ongoing). Concomitant medication(s) included: VALSARTAN HYDROCHLOROTHIAZIDE AKRIKHIN taken for blood pressure abnormal (ongoing); BUPROPION HCL ER taken for depression, anxiety (ongoing); DESVENLAFAXINE SUCCINATE MONOHYDRATE taken for depression, anxiety (ongoing). Vaccination history included: Bnt162b2 (DOSE 1,Time: 04:00 PM, Batch/Lot number: ER8737,Anatomical Site of injection:  left arm,Route of administration: intramuscular), administration date: 01Mar2021, for COVID-19 immunization, reaction(s): "intestinal blockage", "severe constipation"; Bnt162b2 (DOSE 2,Time: 01:00 PM, Batch/Lot number: ER8736,Anatomical Site of injection:  left arm, Route of administration: intramuscular), administration date: 21Apr2021, for COVID-19 immunization, reaction(s): "severe constipation", "inappropriate schedule of vaccine administered". Prior vaccine in four weeks was None. After each dose of the vaccine the patient experienced severe constipation requiring a rectal enema for relief. it is especially important to note that after the 3rd Dose the patient experienced severe abdominal pains, nausea ,diarrhea and vomiting. This event required an urgent care trip where the patient was given a Course of antibiotics and told that the patient most likely had an intestinal infection and / or blockage. The patient have a follow up colonoscopy scheduled for January. The following information was reported: IMMUNISATION (medically significant) with onset 06Nov2021, outcome "unknown", described as "booster"; GASTROINTESTINAL INFECTION (medically significant), outcome "unknown", described as "intestinal infection"; ABDOMINAL PAIN (medically significant), outcome "unknown", described as "severe abdominal pains"; INTESTINAL OBSTRUCTION (medically significant) with onset 12Nov2021, outcome "recovering", described as "intestinal infection or blockage"; NAUSEA (non-serious), outcome "unknown", described as "nausea"; DIARRHOEA (non-serious), outcome "unknown", described as "diarrhea"; VOMITING (non-serious), outcome "unknown", described as "vomiting". The event "intestinal infection or blockage" was evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: blood pressure abnormal: (Jul2014) high; colonoscopy: (2016) unknown results. Therapeutic measures were taken (Rectal enema, antibiotics) as a result of gastrointestinal infection, intestinal obstruction.